S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

SLS SELLAS Life Sciences Group Inc

1.32

-0.03 (-2.22%)

May 03 2024 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more SELLAS Life Sciences Charts.

SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more SELLAS Life Sciences Charts.

Galena Biopharma, Inc. News

Form 8-K - Current report
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 5 January 2024 (4 months ago) • Edgar (US Regulatory)

More Galena Biopharma, Inc. News Articles

Marketing Worldwide (PK)

Bell Buckle (PK)

Yuenglings Ice Cream (PK)

Indoor Harvest (PK)

RespireRx Pharmaceuticals (PK)

Moon Equity (PK)

Umbra Applied Technologies (PK)

Ubiquitech Software (PK)

Brookmount Explorations (PK)

Astra Energy (QB)

Clean Vision (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions